Insider Transactions

What Surface Oncology, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Grayzel David S.	Director	Sep 08	Disposition to Issuer · D	−2,945,453	—	—	0
Sigal Charles Elliott	Director	Sep 08	Disposition to Issuer · D	−45,453	—	—	0
Ross Robert W.	Chief Executive Officer	Sep 08	Disposition to Issuer · D	−83,193	—	—	0
Rath Henry C.	Chief Business Officer	Sep 08	Disposition to Issuer · D	−44,971	—	—	0
Oneill Alison	Chief Medical Officer	Sep 08	Disposition to Issuer · D	−56,686	—	—	0
Goater Jeff	Director	Sep 08	Disposition to Issuer · D	−129,222	—	—	0
Adams Chandra	Deputy GC	Sep 08	Disposition to Issuer · D	−23,884	—	—	0
Fees Jessica	Chief Financial Officer	Sep 08	Disposition to Issuer · D	−101,915	—	—	0
Palombella Vito J.	Chief Scientific Officer	Sep 08	Disposition to Issuer · D	−87,212	—	—	0
Ross Robert W.	Chief Executive Officer	Aug 01	Open-market sale · S	−16,713	$0.94	−$15.7K	83,193
Fees Jessica	Chief Financial Officer	Aug 01	Open-market sale · S	−9,434	$0.94	−$8.87K	101,915
Adams Chandra	Deputy GC	Aug 01	Open-market sale · S	−3,901	$0.94	−$3.67K	30,899
Oneill Alison	Chief Medical Officer	Aug 01	Open-market sale · S	−7,042	$0.94	−$6.62K	56,686
Ross Robert W.	Chief Executive Officer	Aug 03	Open-market sale · S	−10,594	$1.72	−$18.2K	99,906
Oneill Alison	Chief Medical Officer	Aug 03	Open-market sale · S	−4,463	$1.72	−$7.68K	63,728
Palombella Vito J.	Chief Scientific Officer	Aug 03	Open-market sale · S	−4,463	$1.72	−$7.68K	87,212
Fees Jessica	Chief Financial Officer	Aug 03	Open-market sale · S	−5,980	$1.72	−$10.3K	111,349
Rath Henry C.	Chief Business Officer	Aug 03	Open-market sale · S	−5,676	$1.72	−$9.76K	32,324
Ross Robert W.	Chief Executive Officer	Mar 01	Grant / award · A	+56,000	—	—	110,500
Fees Jessica	Chief Financial Officer	Mar 01	Grant / award · A	+38,000	—	—	117,329

Page 1 of 6 · showing the 20 most recent Sign up free to view all 107 transactions and filter by insider →

Comments